Sub-perfluoro-n-octane injection of ocular viscoelastic device assisted inverted internal limiting membrane flap for macular hole retinal detachment surgery: a novel technique

Table 1 Demographics, Main Clinical Features at Baseline, and Surgical Outcomes for Macular Hole Retinal Detachment

Patient No.	Age (Years)	Sex	Eye	Subtype of MHRD^a	Axial length (mm)	MH size (μm)	Retinal attachment	MH closed	Final Lens Status	Preoperative BCVA	Final BCVA	Follow-up (month)
1	60–70	F	OS	Type 2	33.10	48	Yes	Yes	Cataract	20/400	20/400	6
2	50–60	F	OD	Type 1	27.56	214	Yes	Yes	Cataract	20/2000	20/400	7
3	50–60	F	OS	Type 2	29.05	105	Yes	Yes	Pseudophakic	20/1000	20/200	10
4	60–70	F	OS	Type 1	27.52	153	Yes	Yes	Pseudophakic	20/2000	20/400	11
5	70–80	M	OS	Type 1	30.50	28	Yes	Yes	Pseudophakic	20/400	20/200	12
6	60–70	M	OS	Type 1	28.58	114	Yes	Yes	Pseudophakic	20/100	20/50	12
7	50–60	M	OD	Type 2	30.81	NA^b	Yes	Yes	Pseudophakic	20/2000	20/50	7
8	50–60	F	OS	Type 2	31.86	NA^b	Yes	Yes	Cataract	20/2000	20/400	7

BCVA Best-corrected visual acuity, MH Macular hole, NA Not applicable, RD Retinal detachment
^a Type 1 indicated RD confined to the macula (within the boundaries of the superior and inferior temporal arcade vessels), and type 2 indicated RD beyond the macula
^b No clear OCT images could be obtained preoperatively for measurements

ISSN: 1471-2415